OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
246720$6070.0056

Asta Co Ltd

Medical Equipment, Supplies & DistributionVerified

Asta Co Ltd exhibits a high price-to-book ratio of 9.99 and a price-to-tangible-book ratio of 9.99, indicating a premium valuation relative to its book value. The company's liquidity position is strong, with a current ratio of 4.11 and cash and equivalents of KRW 2,906,053,460. However, the company reported negative operating and net income, with operating income of -KRW 258,969,878 and net income of -KRW 3,303,456,540. The company's profitability metrics are weak compared to industry norms. Return on equity (ROE) is -35.81%, and return on assets (ROA) is -21.33%, both significantly below the industry median for medical equipment firms. Gross profit of KRW 1,257,322,950 represents 48.45% of revenue, but this is insufficient to offset operating expenses. Asta Co Ltd's revenue is concentrated in a few key markets, with disclosed applications in display, secondary battery, and semiconductor industries. No segment or geographic breakdown is provided in the latest financials, limiting visibility into diversification. The company's growth trajectory is uncertain, with no outlook data provided for current or next fiscal years. Historical revenue of KRW 2,594,819,140 shows no year-over-year growth data, and the negative operating and free cash flows suggest operational challenges. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has a debt-to-equity ratio of 0.3, indicating a conservative capital structure. No dilution sources were identified in the latest filings. No recent events, such as filings or transcripts, were provided in the input data to inform recent developments or strategic shifts.

30-day price · 246720(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAsta Co Ltd
Ticker246720.KQ
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Asta Co Ltd is a Korea-based company engaged in the manufacture and sale of mass spectrometry equipment, primarily matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) based systems and related consumables, used in display, secondary battery, and semiconductor industries.

Classification. Asta Co Ltd is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Asta Co Ltd exhibits a high price-to-book ratio of 9.99 and a price-to-tangible-book ratio of 9.99, indicating a premium valuation relative to its book value. The company's liquidity position is strong, with a current ratio of 4.11 and cash and equivalents of KRW 2,906,053,460. However, the company reported negative operating and net income, with operating income of -KRW 258,969,878 and net income of -KRW 3,303,456,540. The company's profitability metrics are weak compared to industry norms. Return on equity (ROE) is -35.81%, and return on assets (ROA) is -21.33%, both significantly below the industry median for medical equipment firms. Gross profit of KRW 1,257,322,950 represents 48.45% of revenue, but this is insufficient to offset operating expenses. Asta Co Ltd's revenue is concentrated in a few key markets, with disclosed applications in display, secondary battery, and semiconductor industries. No segment or geographic breakdown is provided in the latest financials, limiting visibility into diversification. The company's growth trajectory is uncertain, with no outlook data provided for current or next fiscal years. Historical revenue of KRW 2,594,819,140 shows no year-over-year growth data, and the negative operating and free cash flows suggest operational challenges. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has a debt-to-equity ratio of 0.3, indicating a conservative capital structure. No dilution sources were identified in the latest filings. No recent events, such as filings or transcripts, were provided in the input data to inform recent developments or strategic shifts.
Key takeaways
  • Asta Co Ltd is overvalued relative to book value, with a price-to-book ratio of 9.99.
  • The company is unprofitable, with negative operating and net income in the latest period.
  • Strong liquidity is offset by poor profitability metrics, including ROE of -35.81%.
  • Revenue concentration in display, secondary battery, and semiconductor industries limits diversification.
  • No immediate liquidity or dilution risks are flagged, but operational performance remains a concern.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$2.59B
Gross profit$1.26B
Operating income-$2.59B
Net income-$3.30B
R&D
SG&A
D&A
SBC
Operating cash flow-$3.35B
CapEx-$29.6M
Free cash flow-$2.78B
Total assets$15.49B
Total liabilities$6.27B
Total equity$9.22B
Cash & equivalents$2.91B
Long-term debt$2.81B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$6070.00
Market cap$92.15B
Enterprise value$92.05B
P/E
Reported non-GAAP P/E
EV/Revenue35.5
EV/Op income
EV/OCF
P/B10.0
P/Tangible book10.0
Tangible book$9.22B
Net cash$99.1M
Current ratio4.1
Debt/Equity0.3
ROA-21.3%
ROE-35.8%
Cash conversion1.0%
CapEx/Revenue-1.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric246720Activity
Op margin-99.8%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-127.3%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin48.5%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-1.1%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity30.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:39 UTC#3de04e62
Market quoteclose KRW 6070.00 · shares 0.02B diluted
no public URL
2026-05-10 05:39 UTC#7eae8c17
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:41 UTCJob: 0ca8db15